King® Guide to Parenteral Admixtures®

Online Edition

Welcome to the King Guide to Parenteral Admixtures Internet Edition.

Enter Login Information



License Agreement


Spring 2024

In this update we added a new monograph for REMDESIVIR.

We also added new stability information to the monographs for EPINEPHRINE HYDROCHLORIDE and REMDESIVIR.

New compatibility information was added to the existing drug monograph FOR ALPROSTADIL, AMPICILLIN SODIUM, AMPICILLIN SODIUM – SULBACTAM SODIUM, BUMETANIDE, CEFEPIME HYDROCHLORIDE, CISATRACURIUM BESYLATE, DEXMEDETOMIDINE HYDROCHLORIDE, EPINEPHRINE HYDROCHLORIDE, FENTANYL CITRATE, FUROSEMIDE, HEPARIN SODIUM, HYDROMORPHONE HYDROCHLORIDE, KETAMINE HYDROCHLORIDE, MORPHINE SULFATE, OCTREOTIDE ACETATE, PIPERACILLIN AND TAZOBACTAM, SILDENAFIL CITRATE, TOTAL PARENTERAL NUTRITION SOLUTIONS, VANCOMYCIN HYDROCHLORIDE, and VASOPRESSIN.
  © 2024 - King Guide Publications, Inc. All rights reserved.